NVCR OVER 200% of potential upsideOver 200% of potential upside, oversold and extreme RSI divergence on the weekly.
Now price is retesting the broken descending wedge
−0.001 BRL
−909.06 M BRL
3.26 B BRL
About NovoCure Limited
Sector
Industry
CEO
Ashley Cordova
Website
Headquarters
St. Helier
Founded
2000
ISIN
BRN2VCBDR008
FIGI
BBG014XJ1BC3
NovoCure Ltd. is an oncology company which engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. Its platform is called the Tumor Treating Field which uses electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. The company was founded by Yoram Palti in 2000 and is headquartered in St. Helier, Jersey.
−43%
−36%
−29%
−22%
−15%
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
−400.00 M
0.00
400.00 M
800.00 M
1.20 B
Revenue
Net income
Net margin %
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
−400.00 M
0.00
400.00 M
800.00 M
1.20 B
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
−400.00 M
0.00
400.00 M
800.00 M
1.20 B
No news here
Looks like there's nothing to report right now
NovoCure Limited (NVCR) to rally 100% ??** short term forecast, days and weeks ahead **
On the above 10 day chart price action has crashed 95% since support failed. Today sellers are trying to push that correction to 100%, are they right?
Unlikely.
1) Price action (not visible on LOG) and RSI resistance breakouts.
2) Support on past r
NVCR CUP AND HANDLENVCR is seriously oversold and has potential for a reversal here. Could be the start of a fresh uptrend. We are currently completing a cup and handle reversal pattern. We have just broken out of the handle. Wait for pullback or enter right away. First target marked on chart as is stop loss. I am ope
NVCR ready to go on an extended run Initial Target by Apr 14 = 99
Target Range by 5/20/2022 = 108-116
Upcoming earnings as a catalyst. Bullish Momentum for pre-earnings run up.
Kept the chart simple but a lot of bullish aspects at play here, to name a few:
- ready for markup coming off an accumulation phase
- completes wave 5 corre
NVCR primed for an extended runKept the chart simple but there are a lot of bullish aspects at play here:
- ready for markup after an accumulation phase
- coming off a wave 5 correction apprx. 0.786 off the highs last June
- looking at weekly chart you’ll see a larger running flat structure
- earnings as a catalyst and overall
See all ideas
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
NVCR5301073
NovoCure Limited 0.0% 01-NOV-2025Yield to maturity
5.55%
Maturity date
Nov 1, 2025
See all N2VC34 bonds